an insight into clinical risk factors for progression in mpns
Published 2 years ago • 450 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
3:49
factors influencing mpn progression
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
4:48
an insight into the management of cytopenias in mf
-
1:26
current and emerging prognostic factors for mds/mpn
-
1:14
an overview of the current and future treatment landscape for mpns
-
1:52
critical insight into therapeutic progress for ctcl
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:06:04
itp: novel treatments
-
5:02
safety and efficacy of amlitelimab in ad: a phase iia rct, s. weidinger et al.
-
3:52
myeloproliferative neoplasms defined: what are et, pv, and mf?
-
1:20
unmet needs in mpn treatment
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:11
personalized risk assessment for transplantation in primary immunodeficiency disorders
-
2:41
an overview of the latest advances in hematology
-
0:52
highlights from icle 2022
-
1:51
novel insights into genomic classification and prognosis in aml
-
2:47
clinical and prognostic implications of wt1 mutations in de novo and r/r aml
-
1:14
highlights in quality management from ebmt
-
2:48
epigenetic profiling and machine learning for risk stratification in pediatric all
-
1:50
criteria for the diagnosis of accelerated/blast phase mpn and challenges clinicians may face
-
1:54
current treatment landscape in classical mpns